These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 16211069)

  • 1. Engineering novel binding proteins from nonimmunoglobulin domains.
    Binz HK; Amstutz P; Plückthun A
    Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered affinity proteins--generation and applications.
    Grönwall C; Ståhl S
    J Biotechnol; 2009 Mar; 140(3-4):254-69. PubMed ID: 19428722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting protein-protein interactions using designed molecules.
    Zhao L; Chmielewski J
    Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered proteins as specific binding reagents.
    Binz HK; Plückthun A
    Curr Opin Biotechnol; 2005 Aug; 16(4):459-69. PubMed ID: 16005204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered protein scaffolds for molecular recognition.
    Skerra A
    J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new generation of protein display scaffolds for molecular recognition.
    Hosse RJ; Rothe A; Power BE
    Protein Sci; 2006 Jan; 15(1):14-27. PubMed ID: 16373474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage display for engineering and analyzing protein interaction interfaces.
    Sidhu SS; Koide S
    Curr Opin Struct Biol; 2007 Aug; 17(4):481-7. PubMed ID: 17870470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
    Watt PM
    Nat Biotechnol; 2006 Feb; 24(2):177-83. PubMed ID: 16465163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening libraries to identify proteins with desired binding activities using a split-GFP reassembly assay.
    Jackrel ME; Cortajarena AL; Liu TY; Regan L
    ACS Chem Biol; 2010 Jun; 5(6):553-62. PubMed ID: 20038141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an "undruggable" class of disease targets.
    Visintin M; Melchionna T; Cannistraci I; Cattaneo A
    J Biotechnol; 2008 May; 135(1):1-15. PubMed ID: 18395925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-idiotypic protein domains selected from protein A-based affibody libraries.
    Eklund M; Axelsson L; Uhlén M; Nygren PA
    Proteins; 2002 Aug; 48(3):454-62. PubMed ID: 12112671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders.
    Chang HJ; Hsu HJ; Chang CF; Peng HP; Sun YK; Yu HM; Shih HC; Song CY; Lin YT; Chen CC; Wang CH; Yang AS
    Structure; 2009 Apr; 17(4):620-31. PubMed ID: 19368895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
    Nygren PA
    FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design.
    Card GL; Blasdel L; England BP; Zhang C; Suzuki Y; Gillette S; Fong D; Ibrahim PN; Artis DR; Bollag G; Milburn MV; Kim SH; Schlessinger J; Zhang KY
    Nat Biotechnol; 2005 Feb; 23(2):201-7. PubMed ID: 15685167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating receptor flexibility in the molecular design of protein interfaces.
    Li L; Liang S; Pilcher MM; Meroueh SO
    Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interactions and selection: generation of molecule-binding proteins on the basis of tertiary structural information.
    Umetsu M; Nakanishi T; Asano R; Hattori T; Kumagai I
    FEBS J; 2010 May; 277(9):2006-14. PubMed ID: 20412054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domains mediate protein-protein interactions and nucleate protein assemblies.
    Costa S; Cesareni G
    Handb Exp Pharmacol; 2008; (186):383-405. PubMed ID: 18491061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.